Prostate & Genitourinary Cancer Clinical Trials
The following is a list of clinical trials with which this cancer care program is currently involved. Talk to your doctor to find out if a clinical trial is right for you.
Kidney Clinical Trials
A Phase 1 Study of BMS-936558 Plus Sunitinib or Pazopanib in Subjects with Metastatic Renal Cell Carcinoma
Kidney
F12005
Ernstoff
A Randomized, Open-Label, Phase 3 Study Of Bms-936558 Vs. Everolimus In Subjects With Advanced Or Metastatic Clear-Cell Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy
Kidney
F12154
Ernstoff
A Study of the Effect of Sorafenib or Regorafenib on p63 Expression and Keratinocyte Differentiation in Human Skin
Kidney
D11004
Danilov
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Kidney
E2805
Seigne
Alternating Targeted Therapy in Patients with Metastatic Renal Cell Carcinoma: A Phase II Study of Alternating Sunitinib and Temsirolimus
Kidney
D1011
Ernstoff
An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
Kidney
F13015
Ernstoff
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Kidney
D0946
Bakitas
Inhibiting the Systemic Autophagic Syndrome - A Phase I/II Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)
Kidney
W12099
Ernstoff
Phase I/II Study of BNC105P in Combination with Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors. Hoosier Oncology Group GU09-145
Kidney
W12123
Ernstoff
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Kidney
FED11061
Pace
Registry Protocol 10PLK13 Proleukin® Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Kidney
F11189
Ernstoff
S0931, EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, a Phase III Study
Kidney
S0931
Ernstoff
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Kidney
AREN0532
Chaffee
Other Male Genital Clinical Trials
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Other Male Genital
D0946
Bakitas
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Other Male Genital
FED11061
Pace
Other Urinary Clinical Trials
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Other Urinary
D0946
Bakitas
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Other Urinary
FED11061
Pace
Prostate Clinical Trials
A Phase III Prospective Randomized Trial Of Dose-Escalated Radiotherapy With Or Without Short-Term Androgen Deprivation Therapy For Patients With Intermediate-Risk Prostate Cancer
Prostate
R0815
Hartford
A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (SPPORT) In Prostate Cancer Patients With A Rising Psa After Radical Prostatectomy
Prostate
R0534
Hartford
A Phase III Trial of the Study of Endocrine Therapy Used as a Cytoreductive and Cytostatic Agent Prior to Radiation Therapy in Good Prognosis Locally Confined Adenocarcinoma of the Prostate
Prostate
R9408
Hartford
A Phase III Trial to Evaluate the Duration of Neoadjuvant Total Androgen Suppression (TAS) and Radiation Therapy (RT) in Intermediate Risk Prostate Cancer
Prostate
R9910
Hartford
A Registry of Sipuleucel-T Therapy in Men with Advanced Prostate Cancer
Prostate
F12017
Schell
Adjuvant Androgen Deprivation Versus Mitoxantrone Plus Prednisone Plus Androgen Deprivation in Selected High Risk Prostate Cancer Patients Following Radical Prostatectomy, Phase III
Prostate
C99904
Seigne
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Prostate
D0946
Bakitas
RTOG 0924: Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Prostate
R0924
Hartford
Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
Prostate
C90203
Seigne
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Prostate
FED11061
Pace
Surgical Margin Assessment During Radical Prostatectomy - a Deformation Study
Prostate
D1003
Halter
Why do Men with Good-Risk Prostate Cancer Choose Treatment Versus Active Surveillance? An Exploratory Investigation
Prostate
D12031
Hegel
Urinary Bladder Clinical Trials
A Phase I/II Trial of A Combination of Paclitaxel and Trastuzumab with Daily Irradiation OR Paclitaxel Alone with Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates with Muscle-Invasive Bladder Cancer
Urinary Bladder
R0524
Hartford
A Phase II Protocol For Patients With Stage T1 Bladder Cancer To Evaluate Selective Bladder Preserving Treatment By Radiation Therapy Concurrent With Cisplatin Chemotherapy Following A Thorough Transurethral Surgical Re-Staging
Urinary Bladder
R0926
Hartford
A Pilot Project to Investigate the Ability of Atomic Force Microscopy to Identify Malignant Cells in the Urine
Urinary Bladder
D12135
Seigne
A Randomized Double-Blind Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma
Urinary Bladder
C90601
Devitskiy
A Tumor Tissue Pharmacodynamic Study of Modified Neoadjuvant Chemotherapy for Muscle-invasive Non-metastatic Transitional Cell Bladder Carcinoma
Urinary Bladder
D12064
Ernstoff
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Urinary Bladder
D0946
Bakitas
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Urinary Bladder
FED11061
Pace
